CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors

Clinical trial NCT02094560 · TERMINATED

Trial details

NCT number: NCT02094560
Sponsor: CellAct Pharma GmbH
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Endstage Solid Carcinomas in Adults

Start date: 2011-11-08
Primary completion: 2015-09-08
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.